Centrum 7/6  banner

2019

Wider role for CVS’ Sansone

Wider role for CVS’ Sansone

WOONSOCKET, R.I. — CVS Pharmacy has expanded the responsibilities of Judy Sansone, the chain’s senior vice president of front-store business and chief merchant. In addition, George Coleman has been promoted to senior vice president of merchandising, reporting to Sansone. He had been vice president of merchandising for consumer health care. Sansone’s team will be responsible

WBA joins Microsoft in health care partnership

WBA joins Microsoft in health care partnership

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and Microsoft Corp. have teamed up to develop new health care delivery models, technology and retail innovations to advance and improve the future of health care. The companies will combine the power of Microsoft Azure, Microsoft’s cloud and artificial intelligence platform, health care investments, and new retail solutions

Case for DIR reform advanced

Case for DIR reform advanced

ARLINGTON, Va. — The National Association of Chain Drug Stores has submitted extensive and thoroughly documented comments to the Centers for Medicare and Medicaid Services (CMS) in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees — reform that relates directly to reducing patients’ out-of-pocket drug costs. NACDS issued its comments

Canada’s pharmacy sector holding strong

Canada’s pharmacy sector holding strong

Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Looking ahead to 2019, the pharmacy business is poised to be more disrupted than ever before. Over the past 10 years, our members have successfully navigated a number of headwinds to their operating and regulatory environments, including price compression, regulatory

Putting patients first and encouraging innovation

Putting patients first and encouraging innovation

Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. For much of 2018, capital markets for biotech investment were strong. Some 53 biotech companies went public with more than $5.4 billion in funding, putting the biotech industry on track for the second-best year for IPOs in a decade. And

Making the Rx markets more competitive again

Making the Rx markets more competitive again

Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. This past June, Secretary of Health and Human Services Alex Azar told the Senate Finance Committee, “We need a strong, robust generic market.” He followed this statement with an observation that resonated for many of the member companies of the

An introduction to the coming cannabis ‘gold rush’

An introduction to the coming cannabis ‘gold rush’

Editor’s note: This is Part I of an article that ran in the 1/21/19 issue of CDR. As legal cannabis-based products continue to find their way to market, promising to redefine entire categories from health, beauty and wellness to food and beverage in their wake, most chain drug retailers are scrambling to calculate the impact

WBA reaping rewards of partnerships

WBA reaping rewards of partnerships

SAN FRANCISCO — During a fireside chat at the annual J.P. Morgan Healthcare Conference here earlier this month, Walgreens Boots Alliance (WBA) co-chief operating officer Alex Gourlay spoke to the number of partnerships the company has brought to the marketplace as well as the future of health care. WBA has always viewed vertical integration positively,

PP_1170x120_10-25-21